SCHEMBL5335864

SCHEMBL5335864

OC(=S)CC1c2ccccc2C=Cc2ccc(/C=C/c3ccc4cc(F)c(Cl)cc4n3)cc21

nearest known ligand 0.37

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYSLTR2 Q9NS75 4/20 0.34
CYSLTR1 Q9Y271 4/20 0.34
PTPN1 P18031 2/20 0.32
KDM4E B2RXH2 3/20 0.31
NPC1 O15118 3/20 0.31
RAB9A P51151 3/20 0.31
ALDH1A1 P00352 2/20 0.31
SMN1; SMN2 Q16637 2/20 0.31
HPGD P15428 1/20 0.31
NFKB1 P19838 1/20 0.31
NFKB2 Q00653 1/20 0.31
RELA Q04206 1/20 0.31
LMNA P02545 2/20 0.31
MEN1 O00255 1/20 0.31
MAPT P10636 1/20 0.31
KMT2A Q03164 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
PKM P14618 1/20 0.31
PTPRC P08575 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5335866 1.00 CYSLTR2 (0.34) CYSLTR2CYSLTR1PTPN1KDM4ENPC1
SCHEMBL5334155 0.91 CYSLTR1 (0.35) CYSLTR2CYSLTR1KDM4ENPC1RAB9A
SCHEMBL5334152 0.91 CYSLTR1 (0.35) CYSLTR2CYSLTR1KDM4ENPC1RAB9A
SCHEMBL5335861 0.89 CYSLTR2 (0.37) CYSLTR2CYSLTR1PTPN1KDM4ENPC1
SCHEMBL5332588 0.88 CYSLTR1 (0.42) CYSLTR2CYSLTR1MEN1KMT2A
SCHEMBL5332585 0.88 CYSLTR1 (0.42) CYSLTR2CYSLTR1MEN1KMT2A
SCHEMBL5337055 0.84 CYSLTR2 (0.36) CYSLTR2CYSLTR1PTPN1KDM4ENPC1
SCHEMBL5337057 0.84 CYSLTR2 (0.36) CYSLTR2CYSLTR1PTPN1KDM4ENPC1
SCHEMBL5339119 0.80 CYSLTR2 (0.38) CYSLTR2CYSLTR1PTPN1MAPTPTPRC
SCHEMBL5339126 0.80 CYSLTR2 (0.38) CYSLTR2CYSLTR1PTPN1MAPTPTPRC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7309718-B2 Dibenzocycloheptene compound UBE INDUSTRIES, LTD. (JP) 2007-12-18 US claimed
US-20040180884-A1 Dibenzocycloheptene compound UBE INDUSTRIES, LTD. (JP) 2004-09-16 US claimed
EP-1408033-A1 DIBENZOCYCLOHEPTENE COMPOUND Ube Industries, Ltd. (JP) 2004-04-14 EP claimed
US-7309718-B2 Dibenzocycloheptene compound UBE INDUSTRIES, LTD. (JP) 2007-12-18 US disclosed
US-20040180884-A1 Dibenzocycloheptene compound UBE INDUSTRIES, LTD. (JP) 2004-09-16 US disclosed
EP-1408033-A1 DIBENZOCYCLOHEPTENE COMPOUND Ube Industries, Ltd. (JP) 2004-04-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040180884-A1 Dibenzocycloheptene compound LTB4R2, LTA4H, LTC4S CYSLTR2 5/4885CYSLTR1 6/4885PTPN1 2636/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.